Liquid Biopsy for Lung Cancer Gets €46M Boost - Labiotech.eu

Liquid Biopsy for Lung Cancer Gets €46M Boost  Labiotech.eu

Inivata has raised a €46M (£40M) Series B round that will further advance the commercialization of the company's blood drop test for lung cancer as well as the ...



Comments

Popular posts from this blog

Stage 4 Lung Cancer Life Expectancy

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Free biotech stocks directory, pharma stocks, telemedicine stocks ...